Abstract
Background: Monoclonal antibodies are nowadays by far the most important of all biotherapeutics. Unfortunately, they are complex proteins, so that their production is complicated and expensive, which eventually leads to an elevated average cost per treatment per patient. An important research effort is dedicated to the development of a process that may allow a reduction of antibodies production costs.
Objective: In particular, the main target is to replace the capture step based on the very expensive use of protein A beads, which is, and has been, the standard for the last 20 years. Among the possible alternatives the use of membrane chromatography for antibody capture will be considered in this work. Despite the development of new convective stationary phases with improved binding capacity, the use of membrane adsorbers for capture chromatography is still limited to niche applications. Conventional packed bead columns are still preferred due to their higher binding capacity even if they suffer from several limitations such as high pressure drop, slow mass transfer through the diffusive pores and strong dependence of the binding capacity on flow rate. An overview of the recent work performed in the field and a critical review of how technology advances could make a breakthrough will be presented here.Keywords: Antibody, affinity, chromatography, immunoglobulin, ion-exchange, membrane adsorbers, purification.
Current Organic Chemistry
Title:Advances in Membrane Chromatography for the Capture Step of Monoclonal Antibodies
Volume: 21 Issue: 17
Author(s): Cristiana Boi*Simone Dimartino
Affiliation:
- Dipartimento di Ingegneria Civile, Chimica, Ambientale e dei Materiali, Università di Bologna, via Terracini 28, 40131 Bologna,Italy
Keywords: Antibody, affinity, chromatography, immunoglobulin, ion-exchange, membrane adsorbers, purification.
Abstract: Background: Monoclonal antibodies are nowadays by far the most important of all biotherapeutics. Unfortunately, they are complex proteins, so that their production is complicated and expensive, which eventually leads to an elevated average cost per treatment per patient. An important research effort is dedicated to the development of a process that may allow a reduction of antibodies production costs.
Objective: In particular, the main target is to replace the capture step based on the very expensive use of protein A beads, which is, and has been, the standard for the last 20 years. Among the possible alternatives the use of membrane chromatography for antibody capture will be considered in this work. Despite the development of new convective stationary phases with improved binding capacity, the use of membrane adsorbers for capture chromatography is still limited to niche applications. Conventional packed bead columns are still preferred due to their higher binding capacity even if they suffer from several limitations such as high pressure drop, slow mass transfer through the diffusive pores and strong dependence of the binding capacity on flow rate. An overview of the recent work performed in the field and a critical review of how technology advances could make a breakthrough will be presented here.Export Options
About this article
Cite this article as:
Boi Cristiana*, Dimartino Simone, Advances in Membrane Chromatography for the Capture Step of Monoclonal Antibodies, Current Organic Chemistry 2017; 21 (17) . https://dx.doi.org/10.2174/1385272820666160610114814
DOI https://dx.doi.org/10.2174/1385272820666160610114814 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Advances of Heterocyclic Chemistry with Pesticide Activity
Global food safety and security will continue to be a global concern for the next 50 years and beyond. Plant diseases have had a significant impact on food safety and security throughout the entire food chain, from primary production to consumption. While conventional chemical pesticides have been traditionally used for ...read more
Calculation design of covalent/metal organic framework based catalysts
This research area combines theoretical computation and screening with machine learning for the design of covalent/metal organic framework-based catalysts, bridging the disciplines of organic chemistry, physical chemistry, computational chemistry, materials science, and machine learning. It covers several critical aspects: designing and synthesizing organic catalysts for improved performance, applying computational methods ...read more
Carbohydrates conversion in biofuels and bioproducts
Biomass pretreatment, hydrolysis, and saccharification of carbohydrates, and sugars bioconversion in biofuels and bioproducts within a biorefinery framework. Carbohydrates derived from woody biomass, agricultural wastes, algae, sewage sludge, or any other lignocellulosic feedstock are included in this issue. Simulation, techno-economic analysis, and life cycle analysis of a biorefinery process are ...read more
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
TGF-β1 Signalling, Connecting Aberrant Inflammation and Colorectal Tumorigenesis
Current Pharmaceutical Design Natural Killer Cells Adjudicate Every Stage of Anti-Viral Immune Response
Current Immunology Reviews (Discontinued) The Chemistry of Epoxy Alcohols
Current Organic Chemistry Influence of Length and Amino Acid Composition on Dimer Formation of Immunoglobulin based Chimera
Current Pharmaceutical Design Biologic and Novel Therapy of the Inflammatory Bowel Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Connexins in Renal Endothelial Function and Dysfunction
Cardiovascular & Hematological Disorders-Drug Targets Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules
Current Medicinal Chemistry Nef: “Necessary and Enforcing Factor” in HIV Infection
Current HIV Research Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents
Medicinal Chemistry Single Stranded DNA Immune Modulators with Unmethylated CpG Motifs: Structure and Molecular Recognition by Toll-Like Receptor 9
Current Protein & Peptide Science Subthreshold Diode Micropulse Laser Photocoagulation (SDM) as Invisible Retinal Phototherapy for Diabetic Macular Edema: A Review
Current Diabetes Reviews Schizophrenia and Liver Dysfunction Caused by Portacaval Shunting
Current Psychiatry Reviews Immunity to Tuberculosis and Novel Therapeutic Strategies
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) Nucleic Acid Enzymes as a Novel Generation of Anti-gene Agents
Current Molecular Medicine Activity-Dependent Neurorehabilitation Beyond Physical Trainings: “Mental Exercise” Through Mirror Neuron Activation
CNS & Neurological Disorders - Drug Targets Graphical Abstracts
Letters in Drug Design & Discovery Perspectives in Biomolecular Therapeutic Intervention in Cancer: From the Early to the New Strategies With Type I Interferons
Current Medicinal Chemistry Evaluating the Effects of Oral and Topical Simvastatin in the Treatment of Acne Vulgaris: A Double-blind, Randomized, Placebo-controlled Clinical Trial
Current Clinical Pharmacology The Association Between the Chronic Use of Non-Steroidal Anti- Inflammatory Drugs and Oxidative and Inflammatory Markers in the Elderly
Inflammation & Allergy - Drug Targets (Discontinued) Thyroglobulin Autoantibodies as Surrogate Biomarkers in the Management of Patients with Differentiated Thyroid Carcinoma
Current Medicinal Chemistry